» Articles » PMID: 39242246

Human-derived Monoclonal Autoantibodies As Interrogators of Cellular Proteotypes in the Brain

Overview
Journal Trends Neurosci
Specialty Neurology
Date 2024 Sep 6
PMID 39242246
Authors
Affiliations
Soon will be listed here.
Abstract

A major aim of neuroscience is to identify and model the functional properties of neural cells whose dysfunction underlie neuropsychiatric illness. In this article, we propose that human-derived monoclonal autoantibodies (HD-mAbs) are well positioned to selectively target and manipulate neural subpopulations as defined by their protein expression; that is, cellular proteotypes. Recent technical advances allow for efficient cloning of autoantibodies from neuropsychiatric patients. These HD-mAbs can be introduced into animal models to gain biological and pathobiological insights about neural proteotypes of interest. Protein engineering can be used to modify, enhance, silence, or confer new functional properties to native HD-mAbs, thereby enhancing their versatility. Finally, we discuss the challenges and limitations confronting HD-mAbs as experimental research tools for neuroscience.

References
1.
Gibson L, McKeever A, Coutinho E, Finke C, Pollak T . Cognitive impact of neuronal antibodies: encephalitis and beyond. Transl Psychiatry. 2020; 10(1):304. PMC: 7463161. DOI: 10.1038/s41398-020-00989-x. View

2.
Andrzejak E, Rabinovitch E, Kreye J, Pruss H, Rosenmund C, Ziv N . Patient-Derived Anti-NMDAR Antibody Disinhibits Cortical Neuronal Networks through Dysfunction of Inhibitory Neuron Output. J Neurosci. 2022; 42(15):3253-3270. PMC: 8994542. DOI: 10.1523/JNEUROSCI.1689-21.2022. View

3.
Trubetskoy V, Pardinas A, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli T . Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022; 604(7906):502-508. PMC: 9392466. DOI: 10.1038/s41586-022-04434-5. View

4.
Ly L, Kreye J, Jurek B, Leubner J, Scheibe F, Lemcke J . Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics. J Neurol. 2018; 265(11):2625-2632. PMC: 6182686. DOI: 10.1007/s00415-018-9042-1. View

5.
Otchy T, Wolff S, Rhee J, Pehlevan C, Kawai R, Kempf A . Acute off-target effects of neural circuit manipulations. Nature. 2015; 528(7582):358-63. DOI: 10.1038/nature16442. View